Imugene Limited IUGNF
0.04 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
0.0238 Day range 0.0238
0.01 52-week range 0.295
- YTD
- -85.00%
- 1 year
- -82.77%
News
proactiveinvestors.com Figma shares rise as Bank of America resumes coverage with a ‘Buy’ rating Figma (NYSE:FIG) was reinstated with a ‘Buy’ rating and a $30 price objective by Bank of America, with the firm arguing that artificial intelligence is...
proactiveinvestors.com Imugene raises $11.1 million to advance azer-cel after complete responses in early cohort Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) is raising about A$11.12 million before costs through a two-tranche placement, strengthening its balance sheet as...
proactiveinvestors.com Shell flags 'significantly higher' gas trading and sells South Africa business - UPDATE Shell PLC (LSE:SHEL, NYSE:SHEL) shares jumped over 2% after it said stronger trading and improved refining margins should support second-quarter...
proactiveinvestors.com Imugene reports second BTKi cohort response - ICYMI Imugene Ltd (ASX:IMU, OTC:IUGNF) earlier this week reported a second complete response in the concurrent Bruton Tyrosine Kinase inhibitor, or BTKi, cohort...
proactiveinvestors.com Imugene CEO details azer-cel trial milestone - ICYMI Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week reported the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor, or...
proactiveinvestors.com Anthropic clears export hurdle for Fable 5, easing a threat to its IPO story The most striking thing about the standoff that ended on Tuesday is not that it ended, but that it happened at all: a US government blocking a US company...
proactiveinvestors.com Imugene reports second complete response in azer-cel BTKi cohort Just a day after reporting the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor (BTKi) cohort of its ongoing Phase 1b azer-cel...
proactiveinvestors.com Fed may adopt leaner communications strategy under Warsh, says Deutsche Bank Federal Reserve communications are likely to become shorter, less reliant on forward guidance and more focused on longer-term economic narratives under new...
proactiveinvestors.com Nasdaq leads Wall Street higher, Dow Jones notches new record as second quarter ends 4:15pm: Best quarter since 2020 Wall Street has wrapped up its best quarter since 2020, with the Dow Jones adding another 0.3% on Friday to close at a fresh...
proactiveinvestors.com Imugene reports first complete response in azer-cel BTKi cohort Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has reported the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor (BTKi) cohort of its...
proactiveinvestors.com FDA Fast Track opens new path for Imugene's Azer-cel - ICYMI Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week announced that the US Food and Drug Administration (FDA) granted Fast Track Designation to its...
proactiveinvestors.com Inside Biotech: FDA fast-track nod sharpens focus on Imugene's off-the-shelf CAR T ambitions CAR T therapies have transformed treatment options for some blood cancers. They have also exposed one of cell therapy's biggest practical limitations: time....
proactiveinvestors.com Thor Energy lifted by hydrogen project update Thor Energy PLC (AIM:THR, OTCQB:THORF, ASX:THR) shares lifted 25%, to 0.75p, after it said Phase-2 survey work at its HY-Range project in South Australia...
proactiveinvestors.com Imugene showcases Azer-Cel progress at ASCO - ICYMI Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week highlighted encouraging clinical progress for its Azer-Cel program after presenting new data at...
proactiveinvestors.com Dow Jones, Nasdaq close at record levels as Trump says US-Iran peace talks are advancing 4:15pm: Peace optimism boosts stocks US stocks finished Monday’s session higher on renewed hopes a peace deal would be struck between the US and Iran, with...
proactiveinvestors.com Costco's value strategy, membership growth support outlook after strong quarter, says Jefferies Costco Wholesale Corporation (NASDAQ:COST, XETRA:CTO) delivered a strong fiscal third quarter performance, with its value-focused strategy, membership...
proactiveinvestors.com Anthropic confidentially files to go public in the US Anthropic said on Monday it has confidentially filed for a US initial public offering, positioning the artificial intelligence company for what could become...
proactiveinvestors.com Iovance Biotherapeutics pushes cell therapy platform into solid tumor market Iovance Biotherapeutics (NASDAQ:IOVA) said it has obtained clearance of an Investigational New Drug application for IOV-5001, extending its next-generation...
proactiveinvestors.com Small Cap Watch: commercial expansion updates drive news flow The S&P/ASX Small Ordinaries Index continued its strong run, climbing 2.28% on Friday to close at 3,501.80 and gaining 2.19% over the past five trading...
proactiveinvestors.com Imugene presents azer-cel data at ASCO as trial expands into new cohort Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has presented new Phase 1b data for its azer-cel cell therapy at the 2026 American Society of Clinical Oncology...